Ion Beam Applications
13.93
17-February-25 03:38:41
15 minutes delayed
Stocks
+0.07
+0.51%
Today's range
13.90 - 13.94
ISIN
BE0003766806
Source
Cboe
-
CONVOCATION À UNE ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE D’IBA SA
09 Mar 2023 10:55:00 By Nasdaq GlobeNewswire
-
25 Jan 2023 12:00:00 By Nasdaq GlobeNewswire
-
10 Jan 2023 01:00:00 By Nasdaq GlobeNewswire
-
IBA signs contract to install a fully integrated X-ray irradiation solution in France
22 Dec 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Wins 10 Proton Therapy System Contract in Spain
08 Dec 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA – Transparency Notification
07 Dec 2022 11:45:00 By Nasdaq GlobeNewswire
-
28 Nov 2022 11:45:00 By Nasdaq GlobeNewswire
-
IBA Business Update – Third Quarter 2022
17 Nov 2022 01:00:00 By Nasdaq GlobeNewswire
-
13 Oct 2022 01:00:00 By Nasdaq GlobeNewswire
-
ElsMed, Novatec and IBA sign contract to install radiopharmaceutical production center in Georgia
04 Oct 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225
22 Sep 2022 01:00:00 By Nasdaq GlobeNewswire
-
20 Sep 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Reports Half Year 2022 Results
31 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA and ScandiDos form strategic alliance to increase access to safe radiotherapy
30 Aug 2022 12:00:00 By Nasdaq GlobeNewswire
-
26 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
02 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
30 Jun 2022 01:00:00 By Nasdaq GlobeNewswire
-
01 Jun 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Business Update – First Quarter 2022
19 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA continues to shape the future of proton therapy at ESTRO 2022 Annual Congress
06 May 2022 01:00:00 By Nasdaq GlobeNewswire